Elanco Animal Health Limited (NYSE:ELAN) Q4 2023 Earnings Conference Call February 26, 2024 8:00 AM ET

Company Participants

Jeff Simmons - President, Chief Executive Officer

Todd Young - Executive Vice President, Chief Financial Officer

Katy Grissom - Head of Investor Relations

Conference Call Participants

Jon Block - Stifel

Erin Wright - Morgan Stanley

Michael Ryskin - Bank of America

Balaji Prasad - Barclays

Umer Raffat - Evercore ISI

Glen Santangelo - Jefferies

Chris Schott - JP Morgan

Chris - TD Cowen

Neven Tai - BNP Paribas

Nathan Rich - Goldman Sachs

Brandon Vazquez - William Blair

Operator

Good morning, my name is Krista and I’ll be your conference Operator today. At this time, I would like to welcome everyone to the Elanco Animal Health fourth quarter earnings conference call.

All lines have been placed on mute to prevent any background noise. After the speakers’ remarks, there will be a question and answer session. If you would like to ask a question during that time, simply press star followed by the number one on your telephone keypad, and if you’d like to withdraw your question, again press star, one. Thank you.

I would now like to turn the conference over to Katy Grissom, Head of Investor Relations. Katie, you may begin.

Katy Grissom

Good morning. Thank you for joining us for Elanco Animal Health’s fourth quarter and full year 2023 earnings call. I’m Katie Grissom, Head of Investor Relations.

Joining me on today’s call are Jeff Simmons, our President and Chief Executive Officer, Todd Young, our Chief Financial Officer, and Scott Purucker from Investor Relations. The slides referenced during this call are available on the Investor Relations section of elanco.com.

Today’s discussion will contain forward-looking statements. These statements are based on our current assumptions and expectations and are subject to risks and uncertainties that could cause actual results to differ materially from our forecast. For more information, see the Risk Factors in today’s earnings press release, as well as our latest Form 10-K and 10-Q filed with the SEC. We do not undertake any duty to update any forward-looking statements.

Our remarks today will focus on our non-GAAP financial measures. Reconciliations of these non-GAAP measures are included in the appendix of today’s sides and in the earnings press release. After our prepared remarks, we’ll be happy to take your questions.

I’ll now turn the call over to Jeff.

Jeff Simmons

Thanks Katy. Good morning everyone. Today Elanco reported fourth quarter and full year results for 2023. Our strong performance last year gives us confidence that are innovation, portfolio and productivity strategy is working and that our actions and investments to launch our new innovations and optimize our core portfolio are paying off. As we enter 2024, we are focused on advancing our strategy to deliver these three priorities: sustained revenue growth, innovation, and improved cash conversion.